Insider Transactions in Q3 2025 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2025
|
Habib J Dable Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,742
-100.0%
|
-
|
|
Jul 17
2025
|
Habib J Dable Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,902
-30.86%
|
-
|
|
Jul 17
2025
|
Michael Landsittel Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
43,175
-100.0%
|
-
|
|
Jul 17
2025
|
Michael Landsittel Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,102
-54.2%
|
-
|
|
Jul 17
2025
|
Michael Landsittel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,353
+18.47%
|
-
|
|
Jul 17
2025
|
Debra Durso Bumpus Chief People Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
19,856
-100.0%
|
-
|
|
Jul 17
2025
|
Debra Durso Bumpus Chief People Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,103
-72.02%
|
-
|
|
Jul 17
2025
|
Debra Durso Bumpus Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,353
+23.13%
|
-
|
|
Jul 17
2025
|
Tracey L Mc Cain EVP & Chief Legal Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
37,092
-100.0%
|
-
|
|
Jul 17
2025
|
Tracey L Mc Cain EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,103
-57.94%
|
-
|
|
Jul 17
2025
|
Tracey L Mc Cain EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,353
+19.49%
|
-
|
|
Jul 17
2025
|
Daniella Beckman Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,842
-100.0%
|
-
|
|
Jul 17
2025
|
Daniella Beckman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,902
-26.47%
|
-
|
|
Jul 17
2025
|
Fouad Namouni PRESIDENT, R & D |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
31,956
-100.0%
|
-
|
|
Jul 17
2025
|
Fouad Namouni PRESIDENT, R & D |
SELL
Sale (or disposition) back to the issuer
|
Direct |
83,281
-72.27%
|
-
|
|
Jul 17
2025
|
Fouad Namouni PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct |
39,456
+25.51%
|
-
|
|
Jul 17
2025
|
Mark Alan Goldberg Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
18,254
-100.0%
|
-
|
|
Jul 17
2025
|
Mark Alan Goldberg Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,902
-17.61%
|
-
|
|
Jul 17
2025
|
Alexis Borisy Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
74,160
-100.0%
|
-
|
|
Jul 17
2025
|
Alexis Borisy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,902
-5.0%
|
-
|
|
Jul 17
2025
|
Kate Haviland Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
70,729
-100.0%
|
-
|
|
Jul 17
2025
|
Kate Haviland Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
224,410
-76.04%
|
-
|
|
Jul 17
2025
|
Kate Haviland Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
129,210
+30.45%
|
-
|
|
Jul 17
2025
|
Christina Rossi Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
20,628
-100.0%
|
-
|
|
Jul 17
2025
|
Christina Rossi Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
82,374
-79.97%
|
-
|
|
Jul 17
2025
|
Christina Rossi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,456
+27.7%
|
-
|
|
Jul 17
2025
|
Percy H. Carter Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,894
-100.0%
|
-
|
|
Jul 17
2025
|
Percy H. Carter Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,614
-75.98%
|
-
|
|
Jul 17
2025
|
Percy H. Carter Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,353
+22.28%
|
-
|
|
Jul 17
2025
|
Lynn Seely Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,254
-100.0%
|
-
|
|
Jul 17
2025
|
Lynn Seely Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,902
-22.74%
|
-
|
|
Jul 17
2025
|
L. Becker Hewes Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,607
-100.0%
|
-
|
|
Jul 17
2025
|
L. Becker Hewes Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,165
-96.9%
|
-
|
|
Jul 17
2025
|
L. Becker Hewes Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,353
+29.2%
|
-
|
|
Jul 17
2025
|
Lonnel Coats Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,144
-100.0%
|
-
|
|
Jul 17
2025
|
John Tsai Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,742
-100.0%
|
-
|
|
Jul 17
2025
|
John Tsai Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,902
-30.86%
|
-
|
|
Jul 17
2025
|
Ariel Hurley Principal Accounting Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,378
-100.0%
|
-
|
|
Jul 17
2025
|
Ariel Hurley Principal Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,146
-82.7%
|
-
|
|
Jul 17
2025
|
Ariel Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,460
+11.19%
|
-
|
|
Jul 17
2025
|
Jeffrey W. Albers Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
144,755
-100.0%
|
-
|
|
Jul 17
2025
|
Jeffrey W. Albers Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,777
-3.84%
|
-
|
|
Jul 17
2025
|
Philina Lee Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,184
-100.0%
|
-
|
|
Jul 17
2025
|
Philina Lee Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,165
-79.19%
|
-
|
|
Jul 17
2025
|
Philina Lee Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,353
+25.21%
|
-
|
|
Jul 03
2025
|
Percy H. Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,051
-1.94%
|
$134,528
$128.25 P/Share
|
|
Jul 03
2025
|
Christina Rossi Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,172
-1.81%
|
$150,016
$128.25 P/Share
|